News & Events about Vapotherm Inc.
Thinking about buying stock in Baudax Bio, Zhihu, Vapotherm, Kingsoft Cloud, or Summit Therapeutics? Thinking about buying stock in Baudax Bio, Zhihu, Vapotherm, Kingsoft Cloud, or Summit Therapeutics? PR Newswire NEW YORK, Dec. 9, 2022 NEW YORK, Dec. 9, 2022 /PRNewswire/ -- InvestorsObserverissues...
Vapotherm (NYSE:VAPO Get Rating) had its price target decreased by Piper Sandler from $5.00 to $2.50 in a research report report published on Thursday, The Fly reports. Piper Sandler currently has an underweight rating on the stock. Several other analysts have also recently weighed in on the company...
Business Wire
8 months ago
Vapotherm, Inc. (NYSE: VAPO) (Vapotherm or the Company), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy products which are used to treat patients of all ages suffering from respiratory distress, today announced...
Ticker Report
9 months ago
Zacks Investment Research downgraded shares of Vapotherm (NYSE:VAPO Get Rating) from a hold rating to a sell rating in a research report report published on Thursday, Zacks.com reports. According to Zacks, Vapotherm Inc. is a medical technology company. It designs and develops ...